NCT02874430 2026-04-22
Metformin Hydrochloride and Doxycycline in Treating Patients With Localized Breast or Uterine Cancer
Thomas Jefferson University
Phase 2 Terminated
Clinical Trials
11 trialsNCT07226453 2026-04-22
PNOC041
University of California, San Francisco
Phase 2 Not yet recruiting
NCT05237960 2026-04-20
Metformin for the Prevention of Oral Cancer in Patients With Oral Leukoplakia or Erythroplakia
University of Arizona
Phase 2 Active not recruiting
NCT02365597 2026-04-13
An Efficacy and Safety Study of Erdafitinib (JNJ-42756493) in Participants With Urothelial Cancer
Janssen Research & Development, LLC
Phase 2 Active not recruiting
NCT02581137 2026-04-13
Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT05966792 2026-04-13
SGLT2 Inhibitors in Treating Patients With PCOS
Shanghai 10th People's Hospital
Phase NA Completed
NCT05445791 2026-04-09
METLUNG
Instituto Nacional de Cancerologia de Mexico
Phase 3 Recruiting
NCT02437656 2026-03-31
METCAP
Centre Oscar Lambret
Phase 2 Completed
NCT05036226 2026-03-30
COAST
Medical University of South Carolina
Phase 1/2 Recruiting
NCT02122185 2026-03-27
Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
University of Chicago
Phase 2 Completed
NCT06899061 2026-03-27
Modular Clinical Pharmacology Study to Evaluate the Drug-drug Interaction Potential and Relative Bioavailability of Saruparib
AstraZeneca
Phase 1 Active not recruiting